Precision Therapeutics Inc., of Minneapolis, which applies artificial intelligence to personalized medicine and drug discovery, said it rebranded as Predictive Oncology Inc. The company said its common stock, currently trading on Nasdaq as AIPT, is expected to begin trading under the Nasdaq ticker POAI on or about June 13.